MAPT and Alzheimer disease: There is growing interest in developing disease-specific biomarkers to aid theprediction of pathology in the antemortem diagnosis of neurodegenerative disorders.Tau and Alzheimer disease pathology-targeted therapies are currently being developedand undergoing clinical trials.